国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YJR037W (YJR037W) CSB-YP341667SVG
CSB-EP341667SVG
CSB-BP341667SVG
CSB-MP341667SVG
CSB-EP341667SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Uncharacterized vacuolar membrane protein YJR054W (YJR054W), partial CSB-YP341668SVG1
CSB-EP341668SVG1
CSB-BP341668SVG1
CSB-MP341668SVG1
CSB-EP341668SVG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae GTPase NPA3 (NPA3) CSB-YP341669SVG
CSB-EP341669SVG
CSB-BP341669SVG
CSB-MP341669SVG
CSB-EP341669SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Cop9 signalosome complex subunit 12 (CSN12) CSB-YP341670SVG
CSB-EP341670SVG
CSB-BP341670SVG
CSB-MP341670SVG
CSB-EP341670SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Diphthamide biosynthesis protein 4 (JJJ3) CSB-YP341671SVG
CSB-EP341671SVG
CSB-BP341671SVG
CSB-MP341671SVG
CSB-EP341671SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Aberrant microtubules protein 1 (ABM1) CSB-YP341672SVG
CSB-EP341672SVG
CSB-BP341672SVG
CSB-MP341672SVG
CSB-EP341672SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Topoisomerase I damage affected protein 4 (TDA4), partial CSB-YP341673SVG1
CSB-EP341673SVG1
CSB-BP341673SVG1
CSB-MP341673SVG1
CSB-EP341673SVG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Sulfite reductase [NADPH] subunit beta (MET5), partial CSB-YP341674SVG
CSB-EP341674SVG
CSB-BP341674SVG
CSB-MP341674SVG
CSB-EP341674SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Cell wall protein DAN1 (DAN1) CSB-YP341675SVG
CSB-EP341675SVG
CSB-BP341675SVG
CSB-MP341675SVG
CSB-EP341675SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Protein COS5 (COS5), partial CSB-YP341676SVG1
CSB-EP341676SVG1
CSB-BP341676SVG1
CSB-MP341676SVG1
CSB-EP341676SVG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loligo pealeii Synaptobrevin, partial CSB-YP341677LQI
CSB-EP341677LQI
CSB-BP341677LQI
CSB-MP341677LQI
CSB-EP341677LQI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Cell division protein FtsA (ftsA) CSB-YP341678EZX
CSB-EP341678EZX
CSB-BP341678EZX
CSB-MP341678EZX
CSB-EP341678EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia xenovorans Biphenyl-2,3-diol 1,2-dioxygenase (bphC) CSB-YP341679BNV
CSB-EP341679BNV
CSB-BP341679BNV
CSB-MP341679BNV
CSB-EP341679BNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium Uncharacterized protein MG007 (MG007) CSB-YP341680MLN
CSB-EP341680MLN
CSB-BP341680MLN
CSB-MP341680MLN
CSB-EP341680MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium Putative ABC transporter ATP-binding protein MG014 (MG014), partial CSB-YP341681MLN1
CSB-EP341681MLN1
CSB-BP341681MLN1
CSB-MP341681MLN1
CSB-EP341681MLN1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium Fructose-bisphosphate aldolase (fba) CSB-YP341682MLN
CSB-EP341682MLN
CSB-BP341682MLN
CSB-MP341682MLN
CSB-EP341682MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium Uncharacterized protein MG029 (MG029) CSB-YP341683MLN
CSB-EP341683MLN
CSB-BP341683MLN
CSB-MP341683MLN
CSB-EP341683MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium Uncharacterized protein MG037 (MG037) CSB-YP341684MLN
CSB-EP341684MLN
CSB-BP341684MLN
CSB-MP341684MLN
CSB-EP341684MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium Uncharacterized lipoprotein MG045 (MG045) CSB-YP341685MLN
CSB-EP341685MLN
CSB-BP341685MLN
CSB-MP341685MLN
CSB-EP341685MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma genitalium Phosphomannomutase (manB), partial CSB-YP341686MLN
CSB-EP341686MLN
CSB-BP341686MLN
CSB-MP341686MLN
CSB-EP341686MLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>